Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling

Alexandria M. Palaferri Schieber; Yujung Michelle Lee; Max W. Chang; Mathias Leblanc; Brett Collins; Michael Downes; Ronald M. Evans; Janelle S. Ayres

doi:10.1126/science.aac6468

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.

Submit a Response to This Article

Compose eLetter

Title

Author Information

Contributors
First name and middle name First or given name, e.g. 'Peter'. Last Name Your last, or family, name, e.g. 'MacMoody'. Email Your email address, e.g. higgs-boson@gmail.com Role / Occupation Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests?

Yes

No

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

No eLetters have been published for this article.

View Full Text

Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling

Plain text

Vertical Tabs

Science

Article Tools